Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer.
Metastatic triple-negative breast cancer (TNBC) is a heterogeneous disease with a poor prognosis and currently with few treatment options. Treatment of these patients is highly based on systemic chemotherapy. Some targeted drugs were recently approved for these patients: two poly(ADP-ribose) polymer...
| Publicado en: | Breast Cancer: Basic & Clinical Research pp. 1 - 15 |
|---|---|
| Autores principales: | , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
1/1/2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |